Integration of cancer genomics with treatment selection

From the genome to predictive biomarkers

Thomas J. Ow, Vlad C. Sandulache, Heath D. Skinner, Jeffrey N. Myers

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The field of cancer genomics is rapidly advancing as new technology provides detailed genetic and epigenetic profiling of human cancers. The amount of new data available describing the genetic make-up of tumors is paralleled by rapid advances in drug discovery and molecular therapy currently under investigation to treat these diseases. This review summarizes the challenges and approaches associated with the integration of genomic data into the development of new biomarkers in the management of cancer.

Original languageEnglish (US)
Pages (from-to)3914-3928
Number of pages15
JournalCancer
Volume119
Issue number22
DOIs
StatePublished - Nov 15 2013

Fingerprint

Genomics
Biomarkers
Genome
Neoplasms
Drug Discovery
Epigenomics
Technology
Therapeutics

Keywords

  • biologic markers
  • clinical trials as topic
  • computational biology
  • genomics
  • molecular targeted therapy
  • neoplasms
  • systems biology
  • therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Integration of cancer genomics with treatment selection : From the genome to predictive biomarkers. / Ow, Thomas J.; Sandulache, Vlad C.; Skinner, Heath D.; Myers, Jeffrey N.

In: Cancer, Vol. 119, No. 22, 15.11.2013, p. 3914-3928.

Research output: Contribution to journalArticle

Ow, Thomas J. ; Sandulache, Vlad C. ; Skinner, Heath D. ; Myers, Jeffrey N. / Integration of cancer genomics with treatment selection : From the genome to predictive biomarkers. In: Cancer. 2013 ; Vol. 119, No. 22. pp. 3914-3928.
@article{118a7011428947a6850b95f68b45f1e4,
title = "Integration of cancer genomics with treatment selection: From the genome to predictive biomarkers",
abstract = "The field of cancer genomics is rapidly advancing as new technology provides detailed genetic and epigenetic profiling of human cancers. The amount of new data available describing the genetic make-up of tumors is paralleled by rapid advances in drug discovery and molecular therapy currently under investigation to treat these diseases. This review summarizes the challenges and approaches associated with the integration of genomic data into the development of new biomarkers in the management of cancer.",
keywords = "biologic markers, clinical trials as topic, computational biology, genomics, molecular targeted therapy, neoplasms, systems biology, therapeutics",
author = "Ow, {Thomas J.} and Sandulache, {Vlad C.} and Skinner, {Heath D.} and Myers, {Jeffrey N.}",
year = "2013",
month = "11",
day = "15",
doi = "10.1002/cncr.28304",
language = "English (US)",
volume = "119",
pages = "3914--3928",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "22",

}

TY - JOUR

T1 - Integration of cancer genomics with treatment selection

T2 - From the genome to predictive biomarkers

AU - Ow, Thomas J.

AU - Sandulache, Vlad C.

AU - Skinner, Heath D.

AU - Myers, Jeffrey N.

PY - 2013/11/15

Y1 - 2013/11/15

N2 - The field of cancer genomics is rapidly advancing as new technology provides detailed genetic and epigenetic profiling of human cancers. The amount of new data available describing the genetic make-up of tumors is paralleled by rapid advances in drug discovery and molecular therapy currently under investigation to treat these diseases. This review summarizes the challenges and approaches associated with the integration of genomic data into the development of new biomarkers in the management of cancer.

AB - The field of cancer genomics is rapidly advancing as new technology provides detailed genetic and epigenetic profiling of human cancers. The amount of new data available describing the genetic make-up of tumors is paralleled by rapid advances in drug discovery and molecular therapy currently under investigation to treat these diseases. This review summarizes the challenges and approaches associated with the integration of genomic data into the development of new biomarkers in the management of cancer.

KW - biologic markers

KW - clinical trials as topic

KW - computational biology

KW - genomics

KW - molecular targeted therapy

KW - neoplasms

KW - systems biology

KW - therapeutics

UR - http://www.scopus.com/inward/record.url?scp=84887079931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887079931&partnerID=8YFLogxK

U2 - 10.1002/cncr.28304

DO - 10.1002/cncr.28304

M3 - Article

VL - 119

SP - 3914

EP - 3928

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 22

ER -